The deacetylase inhibitors—here to stay! H. Miles Prince SPECIAL ISSUE ARTICLE Open access 03 December 2010 Pages: 1 - 2
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect Michael DickinsonRicky W. JohnstoneH. Miles Prince SPECIAL ISSUE ARTICLE Open access 14 December 2010 Pages: 3 - 20
Histone deacetylase inhibitors in Hodgkin lymphoma Daniela BuglioAnas Younes SPECIAL ISSUE ARTICLE Open access 03 December 2010 Pages: 21 - 27
The DAC system and associations with multiple myeloma Enrique M. OcioJesús F. San Miguel SPECIAL ISSUE ARTICLE Open access 01 December 2010 Pages: 28 - 35
The DAC system and associations with acute leukemias and myelodysplastic syndromes Gesine BugOliver G. Ottmann SPECIAL ISSUE ARTICLE Open access 14 December 2010 Pages: 36 - 49
Deactylase inhibition in myeloproliferative neoplasms Sridurga MithraprabhuGeorge GrigoriadisAndrew Spencer SPECIAL ISSUE ARTICLE Open access 03 December 2010 Pages: 50 - 57
Targeting histone deacetyalses in the treatment of B- and T-cell malignancies Jasmine ZainOwen A. O’Connor SPECIAL ISSUE ARTICLE Open access 04 December 2010 Pages: 58 - 78
